Company Information

  

Address: 11119 NORTH TORREY PINES ROAD
SUITE 200 
City: LA JOLLA 
State: CA 
Zip Code: 92037 
Telephone: 858-769-9145 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are an oncology-focused company applying our proprietary Dynamic Tumor Targeting(TM) Platform, or the Platform, to develop differentiated therapies. We were incorporated under the laws of the State of Delaware on November 28, 2005, under the name Tempo Pharmaceuticals, Inc. In October 2008, we changed our name to Cerulean Pharma Inc. Recent Developments In February 2017, we announced that our board of directors initiated a review of strategic alternatives that could result in changes to our business strategy and future operations. As part of this process, our board determined to review alternatives with the goal of maximizing stockholder value, including a potential sale of the company, a reverse merger, a business combination or a sale, license or other disposition of company assets.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/2017-14.66NAN/E
06/2017-88.90NAN/E
03/2017-115.00NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.18Total Liab/Total Assets0.65
Net Inc/Total Assets-1.04Total Liab/Inv Cap1.99
Net Inc/Inv Cap-3.18Total Liab/Comm Equity0.11
Pretax Inc/Net Sales-51.31Interest Coverage Ratio-16.57
Net Inc/Net Sales-51.31Curr Debt/Equity0.64
Cash Flow/Net Sales-43.78LTD/Equity0.34
SG&A/NetSales13.52Total Debt/Equity0.98
Asset Utilization   Liquidity  
Net Receivables Turnover0.47Quick Ratio2.17
Inventory TurnoverNACurrent Ratio2.17
Inventory Day SalesNANet Rec/Curr Assets0.05
Net Sales/Work Cap0.04Inv/Curr AssetsNA
Net Sales/PP&E1.15  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 0.64 1.19 0.77 0.00
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 3.38 3.59 9.99 -5.52
Operating Income -4.03 -5.55 -36.71 22.74
Interest Exp 0.00 0.80 2.24 -1.26
Pretax Income -4.14 -6.34 -38.83 23.93
Other Income -0.11 1.50 NA NA
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -4.14 -6.34 -38.83 23.93

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 7.24 12.03 34.95 38.06
Receivables - Total 0.89 1.14 1.84 1.15
Inventories - Total NA NA NA NA
Total Current Assets 8.13 15.61 36.79 39.20
Net Property, Plant & Equipment 0.02 0.11 0.67 0.70
Total Assets 8.15 15.95 37.69 40.13
Liabilities        
Accounts Payable 0.85 4.18 6.06 7.70
Debt in Current Liabilities 0.00 0.00 8.38 8.19
Total Current Liabilities 3.35 6.68 16.94 15.89
Long-Term Debt 0.00 0.00 4.44 6.55
Total Liabilities 4.09 8.21 24.58 23.51
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings -211.15 -207.02 -200.68 -195.74
Treasury Stock NA NA NA NA
Total Stockholders' Equity 4.06 7.74 13.11 16.62
Total Liabilities and Stockholders' Equity 8.15 15.95 37.69 40.13

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities -5.42 -10.00 -33.33 24.30
Net Cash Provided by Investing Activities 0.62 1.50 -0.42 0.36
Net Cash Provided by Financing Activities 0.01 -14.42 -7.00 3.86

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20120.62-22.10--
12/20130.01-17.14--
12/20140.08-23.34--
12/20150.00-39.59--
12/20160.77-39.30--
Growth Rates5.22----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17214908.11




Report Date : 12/11/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.